ArticleFrontiers in immunology2023

A novel oral formulation of the melanocortin-1 receptor agonist PL8177 resolves inflammation in preclinical studies of inflammatory bowel disease and is gut restricted in rats, dogs, and humans.

John Dodd et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.